Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)

British Journal of Cancer

Volumn 69, Issue 2, 1994, Pages 212-216

  Kusaka, M ^a   Sudo, K ^a   Matsutani, M ^a   Kozai, Y ^a   Marui, S ^a   Fujita, T ^a   Ingber, D ^b   Folkman, J ^b  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUMAGILLOL CHLOROACETYLCARBAMATE; LEUCINE; THYMIDINE; URIDINE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANTIBIOTICS, ANTINEOPLASTIC; CELL COUNT; CELL DIVISION; CELLS, CULTURED; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMAN; LEUCINE; SESQUITERPENES; THYMIDINE; URIDINE;

EID: 0028013224     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1994.41     Document Type: Article

References (11)

1. BICKNELL, R. & HARRIS, A.L. (1991). Novel growth regulatory factors and tumour angiogenesis. Eur. J. Cancer, 27, 781–785.
2. FOLKMAN, J. (1985). Tumor angiogenesis. Adv. Cancer Res., 43, 175–203.
3. FOLKMAN, J. (1990). What is the evidence that tumors are angiogenesis dependent. J. Natl Cancer Inst., 82, 4–6.
4. INGBER, D., FUJITA, T., KISHIMOTO, S., SUDO, K., KANAMARU, T., BREM, H. & FOLKMAN, J. (1990). Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature, 348, 555–557.
5. KLAGSBRUN, M. & D’AMORE, P.A. (1991). Regulators of angiogenesis. Annu. Rev. Physiol, 53, 217–239.
6. KUSAKA, M., SUDO, K., FUJITA, T., MARUI, S., ITOH, F., INGBER, D., & FOLKMAN, J. (1991). Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem. Biophys. Res. Commun., 174, 1070–1076.
7. MAIONE, T.E. & SHARPE, R. (1990). Development of angiogenesis inhibitors for clinical applications. Trends Pharmacol. Sci., 11, 457–461.
8. MARUI, S., ITOH, F., KOZAI, Y., SUDO, K. & KISHIMOTO, S. (1992). Chemical modification of fumagillin. I. 6-O-acyl, 6-O-sulfonyl, 6-O-alkyl, and 6-0-(N-substituted carbamoyl) fumagillols. Chem. Pharm. Bull., 40, 96–101.
9. MOSMAN, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods, 65, 55–63.
10. PEACOCK, D.J., BANQUERICO, M L. & BRAHN, E. (1992). Angiogenesis inhibitor suppresses collagen arthritis. J. Exp. Med., 175, 1135–1138.
11. WEIDNER, N., FOLKMAN, J., POZZA, F., BEVILACQUA, P., ALLRED, N., MOORE, D.H., MELI, S. & GASPARINI, G. (1992). Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl Cancer Inst., 84, 1875–1887.